# Allergy Relief

NDC: 68016-294
Generic name: Cetirizine hydrochloride
Labeler / Manufacturer: CHAIN DRUG CONSORTIUM
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20191101
Marketing ended: 20260731
FDA application: ANDA209274

## Active ingredients

- CETIRIZINE HYDROCHLORIDE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68016-294"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68016-294
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e0ef968-dff3-4446-8412-8085677332f0